In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 27th, 2005 | 18 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.75 | 5.28 | -8 | 0 | 3 | 0 | 39 | 236.274 | 2 | ↓ |
Lo Low (pH 4.5-6) | 2.75 | 5.76 | -40.23 | 1 | 3 | 1 | 40 | 237.282 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.41 | Binding ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5000 | 0.41 | Binding ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5000 | 0.41 | Binding ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 5000 | 0.41 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 5000 | 0.41 | Binding ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 5000 | 0.41 | Binding ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 5000 | 0.41 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 5000 | 0.41 | Binding ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
CDO in myogenesis | |
DSCAM interactions | |
ERK/MAPK targets | |
KSRP destabilizes mRNA | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
Platelet sensitization by LDL | |
VEGFA-VEGFR2 Pathway |